"Rho(D) Immune Globulin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunizing agent containing IMMUNOGLOBULIN G anti-Rho(D) used for preventing Rh immunization in Rh-negative individuals exposed to Rh-positive red blood cells.
| Descriptor ID |
D018029
|
| MeSH Number(s) |
D12.776.124.486.485.114.619.393.700 D12.776.124.790.651.114.619.393.700 D12.776.377.715.548.114.619.393.700
|
| Concept/Terms |
Rho(D) Immune Globulin- Rho(D) Immune Globulin
- Rho(D) Immune Human Globulin
- Immune Globulin, Rh
- Anti-D-Immunoglobulin
- Anti D Immunoglobulin
- Rh Immune Globulin
- Globulin, Rh Immune
|
Below are MeSH descriptors whose meaning is more general than "Rho(D) Immune Globulin".
Below are MeSH descriptors whose meaning is more specific than "Rho(D) Immune Globulin".
This graph shows the total number of publications written about "Rho(D) Immune Globulin" by people in this website by year, and whether "Rho(D) Immune Globulin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Rho(D) Immune Globulin" by people in Profiles.
-
George JN, Vesely SK, Woolf SH. Conflicts of interest and clinical recommendations: comparison of two concurrent clinical practice guidelines for primary immune thrombocytopenia developed by different methods. Am J Med Qual. 2014 Jan-Feb; 29(1):53-60.
-
Armour KL, Parry-Jones DR, Beharry N, Ballinger JR, Mushens R, Williams RK, Beatty C, Stanworth S, Lloyd-Evans P, Scott M, Clark MR, Peters AM, Williamson LM. Intravascular survival of red cells coated with a mutated human anti-D antibody engineered to lack destructive activity. Blood. 2006 Apr 01; 107(7):2619-26.
-
Bolton-Maggs P, Tarantino MD, Buchanan GR, Bussel JB, George JN. The child with immune thrombocytopenic purpura: is pharmacotherapy or watchful waiting the best initial management? A panel discussion from the 2002 meeting of the American Society of Pediatric Hematology/Oncology. J Pediatr Hematol Oncol. 2004 Feb; 26(2):146-51.
-
George JN, Raskob GE, Vesely SK, Moore D, Lyons RM, Cobos E, Towell BL, Klug P, Guthrie TH. Initial management of immune thrombocytopenic purpura in adults: a randomized controlled trial comparing intermittent anti-D with routine care. Am J Hematol. 2003 Nov; 74(3):161-9.
-
Vesely SK, Buchanan GR, Adix L, George JN, Cohen AR, Blanchette VS, Kühne T. Self-reported initial management of childhood idiopathic thrombocytopenic purpura: results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001. J Pediatr Hematol Oncol. 2003 Feb; 25(2):130-3.
-
George JN. Initial management of adults with idiopathic (immune) thrombocytopenic purpura. Blood Rev. 2002 Mar; 16(1):37-8.
-
George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, Blanchette VS, Bussel JB, Cines DB, Kelton JG, Lichtin AE, McMillan R, Okerbloom JA, Regan DH, Warrier I. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996 Jul 01; 88(1):3-40.